Amanote Research

Amanote Research

    RegisterSign In

Can We Use Interleukin-1β Blockade for Lung Cancer Treatment?

Translational Lung Cancer Research - Hong Kong
doi 10.21037/tlcr.2018.03.15
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

April 1, 2018

Authors
Adrian GottschlichStefan EndresSebastian Kobold
Publisher

AME Publishing Company


Related search

Can We Use Nanotechnology to Treat Cancer?

Frontiers for Young Minds
2016English

What Can We Learn Regarding Immunotherapy From Lung Cancer

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

MA09.05 Can We Predict Radiosensitivity in Non-Small Cell Lung Cancer?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Lung Cancer Producing Interleukin-6.

Internal Medicine
Internal MedicineMedicine
1996English

How Can We Prevent Cancer?

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Can We Prevent Breast Cancer?*

British Journal of Cancer
Cancer ResearchOncology
1991English

Monitoring and Caring for Breast Cancer Patients With Post-Treatment Problems: What Can We Do?

Breast Cancer Management
OncologyRadiologyNuclear MedicineImaging
2012English

Can We Use a Biomarker to Guide Antibiotic Treatment in Severe COPD Exacerbations?

Breathe
PulmonaryRespiratory Medicine
2019English

How Can We Breed for More Water Use-Efficient Sugarcane?

Journal of Experimental Botany
Plant SciencePhysiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy